199 related articles for article (PubMed ID: 21035495)
21. Correlation of fragile histidine triad (Fhit) protein structural features with effector interactions and biological functions.
Pichiorri F; Okumura H; Nakamura T; Garrison PN; Gasparini P; Suh SS; Druck T; McCorkell KA; Barnes LD; Croce CM; Huebner K
J Biol Chem; 2009 Jan; 284(2):1040-9. PubMed ID: 19004824
[TBL] [Abstract][Full Text] [Related]
22. Comparative genomic mapping of the bovine Fragile Histidine Triad (FHIT) tumour suppressor gene: characterization of a 2 Mb BAC contig covering the locus, complete annotation of the gene, analysis of cDNA and of physiological expression profiles.
Uboldi C; Guidi E; Roperto S; Russo V; Roperto F; Di Meo GP; Iannuzzi L; Floriot S; Boussaha M; Eggen A; Ferretti L
BMC Genomics; 2006 May; 7():123. PubMed ID: 16719907
[TBL] [Abstract][Full Text] [Related]
23. Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.
Ishii H; Mimori K; Vecchione A; Sutheesophon K; Fujiwara T; Mori M; Furukawa Y
Biochem Biophys Res Commun; 2004 Apr; 316(4):1088-93. PubMed ID: 15044096
[TBL] [Abstract][Full Text] [Related]
24. Positions of chromosome 3p14.2 fragile sites (FRA3B) within the FHIT gene.
Zimonjic DB; Druck T; Ohta M; Kastury K; Croce CM; Popescu NC; Huebner K
Cancer Res; 1997 Mar; 57(6):1166-70. PubMed ID: 9067288
[TBL] [Abstract][Full Text] [Related]
25. Selective monitoring of the enzymatic activity of the tumor suppressor Fhit.
Hacker SM; Mortensen F; Scheffner M; Marx A
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10247-50. PubMed ID: 25098403
[TBL] [Abstract][Full Text] [Related]
26. FHIT loss-induced DNA damage creates optimal APOBEC substrates: Insights into APOBEC-mediated mutagenesis.
Waters CE; Saldivar JC; Amin ZA; Schrock MS; Huebner K
Oncotarget; 2015 Feb; 6(5):3409-19. PubMed ID: 25401976
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylation of the human Fhit tumor suppressor on tyrosine 114 in Escherichia coli and unexpected steady state kinetics of the phosphorylated forms.
Garrison PN; Robinson AK; Pekarsky Y; Croce CM; Barnes LD
Biochemistry; 2005 Apr; 44(16):6286-92. PubMed ID: 15835917
[TBL] [Abstract][Full Text] [Related]
28. Activation state-dependent interaction between Gαq subunits and the Fhit tumor suppressor.
Zuo H; Chan GP; Zhu J; Yeung WW; Chan AS; Ammer H; Wong YH
Cell Commun Signal; 2013 Aug; 11():59. PubMed ID: 23947369
[TBL] [Abstract][Full Text] [Related]
29. Small-Molecule Inhibitors of the Tumor Suppressor Fhit.
Lange S; Hacker SM; Schmid P; Scheffner M; Marx A
Chembiochem; 2017 Sep; 18(17):1707-1711. PubMed ID: 28643453
[TBL] [Abstract][Full Text] [Related]
30. An FHIT tumor suppressor gene?
Le Beau MM; Drabkin H; Glover TW; Gemmill R; Rassool FV; McKeithan TW; Smith DI
Genes Chromosomes Cancer; 1998 Apr; 21(4):281-9. PubMed ID: 9559339
[TBL] [Abstract][Full Text] [Related]
31. The role of deletions at the FRA3B/FHIT locus in carcinogenesis.
Huebner K; Druck T; Siprashvili Z; Croce CM; Kovatich A; McCue PA
Recent Results Cancer Res; 1998; 154():200-15. PubMed ID: 10027001
[TBL] [Abstract][Full Text] [Related]
32. Cancer prevention and therapy in a preclinical mouse model: impact of FHIT viruses.
Ishii H; Vecchione A; Fong LY; Zanesi N; Trapasso F; Furukawa Y; Baffa R; Huebner K; Croce CM
Curr Gene Ther; 2004 Mar; 4(1):53-63. PubMed ID: 15032614
[TBL] [Abstract][Full Text] [Related]
33. Fhit deficiency-induced global genome instability promotes mutation and clonal expansion.
Miuma S; Saldivar JC; Karras JR; Waters CE; Paisie CA; Wang Y; Jin V; Sun J; Druck T; Zhang J; Huebner K
PLoS One; 2013; 8(11):e80730. PubMed ID: 24244712
[TBL] [Abstract][Full Text] [Related]
34. A mouse model of the fragile gene FHIT: From carcinogenesis to gene therapy and cancer prevention.
Zanesi N; Pekarsky Y; Croce CM
Mutat Res; 2005 Dec; 591(1-2):103-9. PubMed ID: 16085127
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms shaping the mutational landscape of the FRA3B/FHIT-deficient cancer genome.
Saldivar JC; Park D
Genes Chromosomes Cancer; 2019 May; 58(5):317-323. PubMed ID: 30242938
[TBL] [Abstract][Full Text] [Related]
36. Identification of Fhit as a post-transcriptional effector of Thymidine Kinase 1 expression.
Kiss DL; Waters CE; Ouda IM; Saldivar JC; Karras JR; Amin ZA; Mahrous S; Druck T; Bundschuh RA; Schoenberg DR; Huebner K
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):374-382. PubMed ID: 28093273
[TBL] [Abstract][Full Text] [Related]
37. Fhit modulates the DNA damage checkpoint response.
Ishii H; Mimori K; Inoue H; Inageta T; Ishikawa K; Semba S; Druck T; Trapasso F; Tani K; Vecchione A; Croce CM; Mori M; Huebner K
Cancer Res; 2006 Dec; 66(23):11287-92. PubMed ID: 17145874
[TBL] [Abstract][Full Text] [Related]
38. Engineering human Fhit, a diadenosine triphosphate hydrolase, into an efficient dinucleoside polyphosphate synthase.
Huang K; Frey PA
J Am Chem Soc; 2004 Aug; 126(31):9548-9. PubMed ID: 15291552
[TBL] [Abstract][Full Text] [Related]
39. The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a patched-related gene, TRC8.
Gemmill RM; West JD; Boldog F; Tanaka N; Robinson LJ; Smith DI; Li F; Drabkin HA
Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9572-7. PubMed ID: 9689122
[TBL] [Abstract][Full Text] [Related]
40. Expression of FRA16D/WWOX and FRA3B/FHIT genes in hematopoietic malignancies.
Ishii H; Vecchione A; Furukawa Y; Sutheesophon K; Han SY; Druck T; Kuroki T; Trapasso F; Nishimura M; Saito Y; Ozawa K; Croce CM; Huebner K; Furukawa Y
Mol Cancer Res; 2003 Nov; 1(13):940-7. PubMed ID: 14638866
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
